Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Sapienza MR"'
Autor:
Mannu C, anna gazzola, Bacci F, Sabattini E, Sagramoso C, Roncolato F, Maura Rossi, Maria Antonella Laginestra, Sapienza MR, Agostinelli C, Antonio De Leo, Piccioli M, Righi S, Artioli P, Chilli L, Da Pozzo G, De Biase G, Sandri F, Sa, Pileri, Pp, Piccaluga
Publikováno v:
anna gazzola
Europe PubMed Central
Antonella
Europe PubMed Central
Antonella
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0e6ca190b15ed0ad1b1ec34922366183
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22432078/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22432078/?tool=EBI
Autor:
Alberti-Violetti, S (AUTHOR), Del Corvo, M (AUTHOR), Melle, F (AUTHOR), Motta, G (AUTHOR), Sapienza, MR (AUTHOR), Venegoni, L (AUTHOR), Cerroni, L (AUTHOR), Cota, C (AUTHOR), Pileri, A (AUTHOR), Pileri, S (AUTHOR), Berti, E (AUTHOR)
Publikováno v:
European Journal of Cancer. 2022 Supplement 1, Vol. 173, pS8-S8. 1p.
Autor:
Claudia Mannu, Anna Gazzola, Maria Antonella Laginestra, Gian Matteo Rigolin, Antonio Cuneo, Simona Righi, Stefano Pileri, Marco Luciani, Fabio Fuligni, Pier Paolo Piccaluga, Maria Ciccone, Maura Rossi, Maria Rosaria Sapienza, Claudio Agostinelli
Publikováno v:
BioMed Research International, Vol 2013 (2013)
BioMed Research International
BioMed Research International
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) is the commonest leukemia in adults. Here, we aimed to evaluate hsa-miR-15a/hsa-miR-16-1 expression in CLL tissues by qPCR and correlate it with the other clinicopathological features and
Autor:
Pier Paolo Piccaluga, Claudia Mannu, Maria Teresa Sista, Maura Rossi, Francesco Bacci, Claudio Agostinelli, Anna Gazzola, Maria Rosaria Sapienza, Elena Sabattini, Pier Luigi Zinzani, Simona Righi, Stefano Pileri, Philip Went
Publikováno v:
Journal of Clinical Pathology. 64:83-87
Aims Peripheral T cell lymphoma not otherwise specified (PTCL/NOS) is the commonest PTCL subtype. Recently, proliferation pathways have been found to be commonly altered in PTCL/NOS. CDKN1B/p27, a critical regulator of cell cycle and proliferation, h
Publikováno v:
Expert Review of Hematology. 5:353-355
In cutaneous infiltrates, tumor cells mostly interest the dermis, sparing the epidermis, but eventually extend to subcutaneous fat. Lymph nodes are diffusely effaced in both the interfollicular areas and medulla, with the typical pattern of leukemic
Autor:
P. L. Tazzari, Maria Rosaria Sapienza, Francesco Alviano, Claudio Agostinelli, Maria Antonella Laginestra, Pier Luigi Zinzani, Claudio Tripodo, Simona Righi, Francesca Ricci, Giorgio Inghirami, Philip Went, A De Renzo, Fabio Fuligni, Pier Paolo Piccaluga, Manuela Mancini, G. P. Bagnara, Davide Gibellini, Sa Pileri, Anna Gazzola, Maura Rossi
Peripheral T-cell lymphomas not otherwise specified (PTCL/NOS) are very aggressive tumors characterized by consistent aberrant expression of platelet-derived growth factor receptor alpha (PDGFRA). In this study, we aimed to identify the determinants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5834011fae7674da9c084208449e7eaa
http://hdl.handle.net/11585/261904
http://hdl.handle.net/11585/261904
Autor:
Anna Gazzola, Pier Paolo Piccaluga, Maria Rosaria Sapienza, Maria Antonella Laginestra, Stefano Pileri, Maura Rossi
Publikováno v:
Advances in Hematology, Vol 2012 (2012)
Advances in Hematology
Advances in Hematology
In the last years, several studies of molecular profiling of aggressive lymphomas were performed. In particular, it was shown that DLBCL can be distinguished in two different entities according to GEP. Specifically, ABC and GCB subtypes were characte
Autor:
Simona Righi, Anna Gazzola, Maria Antonella Laginestra, Elena Sabattini, Francesco Bacci, Carlo A. Sagramoso-Sacchetti, Claudio Agostinelli, Claudia Mannu, Pier Paolo Piccaluga, Maria Rosaria Sapienza, Maria Teresa Sista, Claudio Tripodo, Stefano Pileri, Maura Rossi
Publikováno v:
Advances in Hematology
Università degli Studi di Palermo-IRIS
Advances in Hematology, Vol 2011 (2011)
Università degli Studi di Palermo-IRIS
Advances in Hematology, Vol 2011 (2011)
Despite its well-known histological and clinical features, Hodgkin's lymphoma (HL) has recently been the object of intense research activity, leading to a better understanding of its phenotype, molecular characteristics, histogenesis, and possible me
Autor:
Alessandro Isidori, Stefania Paolini, Meris Donati, Elena Sabattini, Simona Righi, Claudia Mannu, Antonella Laginestra, Anna Gazzola, Nicola Vianelli, Claudio Agostinelli, Roberto Emiliani, Carlo Finelli, Michele De Nictolis, Massimo Valentini, Francesco Alesiani, Maura Rossi, Pier Paolo Piccaluga, Stefano Pileri, Stefano Ascani, Maria Rosaria Sapienza, Giovanni Martinelli, Giuseppe Visani, Ilaria Iacobucci
Abstract 1890 Poster Board I-913 Background. Primary myelofibrosis (PMF) is a clonal myeloproliferative neoplasm (MPN) characterised by a proliferation of predominantly megakaryocytes and granulocytes in bone marrow that in fully developed disease is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64d1ad2457a22fd2c9a24e7ce5211073
http://hdl.handle.net/11585/121698
http://hdl.handle.net/11585/121698
Autor:
Siciliano MC; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Bertolazzi G; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.; Department of Economics, Business, and Statistics, University of Palermo, Palermo, Italy., Morello G; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Tornambè S; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Del Corvo M; Istituto Europeo di Oncologia (IEO), IRCSS Milano, Milan, Italy., Granai M; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Sapienza MR; Istituto Europeo di Oncologia (IEO), IRCSS Milano, Milan, Italy., Leahy CI; School of Medicine, Bernal Institute, Health Research Institute and Limerick Digital Cancer Research Centre, University of Limerick, Limerick, Ireland., Fennell E; School of Medicine, Bernal Institute, Health Research Institute and Limerick Digital Cancer Research Centre, University of Limerick, Limerick, Ireland., Belmonte B; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Arcuri F; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Vannucchi M; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Mancini V; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Guazzo R; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Boccacci R; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Onyango N; Department of Medical Microbiology and Immunology, University of Nairobi, Nairobi, Kenya., Nyagol J; Department of Human Pathology, University of Nairobi, Nairobi, Kenya., Santi R; Department of Pathology, University of Florence, Florence, Italy., Di Stefano G; Department of Pathology, University of Florence, Florence, Italy., Ferrara D; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Bellan C; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Marafioti T; Department of Cellular Pathology, University College London, London, United Kingdom., Ott G; AbteilungfürKlinischePathologie, Robert-Bosch-Krankenhaus and Dr. Margarete Fischer-Bosch InstitutfürKlinischePharmakologie, Stuttgart, Germany., Siebert R; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany., Quintanilla-Fend L; Institut für Pathologie und Neuropathologie, University of Tubingen, Tubingen, Germany., Fend F; Institut für Pathologie und Neuropathologie, University of Tubingen, Tubingen, Germany., Murray P; School of Medicine, Bernal Institute, Health Research Institute and Limerick Digital Cancer Research Centre, University of Limerick, Limerick, Ireland., Tripodo C; School of Medicine, Bernal Institute, Health Research Institute and Limerick Digital Cancer Research Centre, University of Limerick, Limerick, Ireland.; Tumor and Microenvironment Histopathology Unit, IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy., Pileri S; Istituto Europeo di Oncologia (IEO), IRCSS Milano, Milan, Italy., Lazzi S; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Leoncini L; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Publikováno v:
Blood advances [Blood Adv] 2024 Aug 27; Vol. 8 (16), pp. 4330-4343.